A Northwestern Medicine survey found that nearly one in five surgical surgical residents have experienced frequent bullying and that women and racial or ethnic minorities were more likely to report frequent bullying in surgical residency programs.
Browsing: Clinical Breakthroughs
For the first time, Northwestern Medicine surgeons performed a double-lung transplant on a patient whose lungs were irreversibly damaged by COVID-19.
In women with early-stage breast cancer, Northwestern Medicine investigators found chemoendocrine therapy was associated with greater cognitive impairment at three and six months compared to endocrine therapy alone.
Children with COVID-19 experience severe illness less frequently than adults, but the disease can still be dangerous, according to a recent study.
According to several recent editorials published by Feinberg faculty, there are large and complex issues to grapple with, from COVID-19’s devastating impact on African-Americans to maintaining critical care standards in the face of an unprecedented pandemic.
ISGMH Awarded $13.7 Million to Study HIV, Relationships and Substance Use in Sexual and Gender Minorities
Northwestern’s Institute for Sexual and Gender Minority Health and Wellbeing was recently awarded a $13.7 million, five-year grant from the National Institute on Drug Abuse to advance and expand its innovative RADAR research program on HIV, relationships, and substance use among young men who have sex with men, transgender women, and nonbinary individuals assigned male at birth in Chicago.
Jaline Gerardin, PhD, assistant professor of Preventive Medicine in the Division of Epidemiology, discussed how data modeling has helped evaluate COVID-19 transmission rates and containment efforts in Illinois during a recent IPHAM webinar.
Coronary artery calcium levels may help clinicians better identify patients with a higher risk of atherosclerotic cardiovascular disease who will benefit from taking aspirin to prevent a heart attack.
Northwestern University scientists have developed a new method for testing for SARS-CoV-2 (the virus that causes COVID-19) antibodies, requiring only a single drop of blood collected from a simple finger prick.
Investigators at Northwestern University and Shirley Ryan AbilityLab in Chicago have developed a novel wearable device and are creating a set of data algorithms specifically tailored to catch early signs and symptoms associated with COVID-19.